Inverness receives USDA license for AI test kit

Inverness Medical Innovations, a provider of
near-patient diagnostics, monitoring and health management solutions, announces
that it has received licensure from the USDA to manufacture, market and
distribute the BinaxNOWÂ® Avian Influenza Virus Type A Antigen Test Kit.

It is reported that Inverness is the only manufacturer
to have two versions of their rapid antigen test kit for influenza: one USDA
licensed for veterinary use and the other FDA cleared for human use.

The BinaxNOW AI Antigen Test is an easy-to-use, rapid immunochromatographic
test (ICT) that detects influenza A nucleoproteins in chicken, turkey and duck
samples. The company states that use of the BinaxNOW AI test enables early and
accurate identification of influenza A nucleoproteins, facilitating the
implementation of appropriate and cost-effective action plans. Test results are
said to be available in 15 minutes.